Member Info for PL75

You’re aware there’s a rumour, but not of the rumour. Head to maccies and get yourself a filet o fish. Always plenty good stuff being predicted in there, you’ll get a timeline if you’re lucky

Rotate your chart 90 degrees anti-clockwise. Problem solved.

Lovely to see some one liner dribblers joining us today.

Go ahead then... where is the evidence?

I can't buy on HL.

Anyone got the latest price?

This isn’t the usual P&D maccies crew. Looks like a position is being taken and any idiot retail shorters have filled their pampers and had to buy as well

You need to get that seen too. If you want to see full value and the pipeline of assets head in to the clinic and ultimately the market earnings billions, it’s going to be squeaky for many years.

Courtesy of TTB…

‘The Head of Program Innovation (Global Drug Development) at $230B Novartis is meeting #AVCT this week in Boston.

…and she’s stating some are calling preCISION ‘paradigm changer’ in her post.’

Suppose they are neighbours in White City. Word gets around.

They’ve gone with a poison pill defence given their lowly market cap. The market can be thick as mince, with a large disconnect between true value and the market, whilst shareholders can be protected from the stupidity.

Wow. Bit of detail here…

https://www.fiercebiotech.com/biotech/tempests-triplet-treatment-had-advantage-over-roche-combo-liver-cancer

So, it was based on the results of 40 patients on their treatment. They increased the progression free survival rate to 7 from 4.27. Their next move is a pivotal study.

Meanwhile, AVA6k continues to be given to end of life patients from earlier cohorts and never mind PFS, some patients are seeing large reductions in their tumours. Next up, subject to approvals, a pivotal study.

3000%+ please….

Been proven several times, clickbait garbage from the equivalent of motley fool or yahoo finance. Not worth air time.

They’re all the SAME ROOM. Alan microwaved some fish the other day, that caused quite an argument.

Imagine if we stayed above that ******* ******* **** 137p this time. Totally agree, feels like the fundamentals are starting to shine through, the stunning results could only be ignored for so long. We even stayed steady after an Alan presentation.

Value will always out.

Yeboha let the side down. The sealion was arfing in to the abyss. Best left that way. Get your own dartboard, blindfold and brown crayons and ignore this garbage.

1.87 to be precise. Hi RD, looking forward to another ‘top up’

I care . I’d hate to see those imaginary profits wasted in, I don’t know, say he put them in a debt ridden mess on a spike. Be careful with your fantasy trades folks. Don’t sell out twice at the bottom before making 42%, imagine how much you could have imagined you could have pretended to make.

Unfair, Sujood correctly predicted an RNS on the day of the financial results, so he’s quite the soothsayer. Who else could have seen that coming? (apart from everyone else)

Poor trolling effort. This spammer sold not once but twice at the bottom. Difficult to keep up with you own rollocks I suppose.

Anyway, here’s hoping no news and we keep the vinegar strokes going for a while longer.

Which share?

Yes, China has been excluded from the sales of affidx. So has the rest of the world incidentally due to The Great Ink Shortage of 2021.

In May 2010 I paid for a pizza using bitcoins. Last I heard the pizza place owner was scrabbling around making money by peddling lies on companies that are trying to cure cancer. A sad tale all around.